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Abstract:  Unlike transport vesicles or organelles, human adenovirus (HAdV) directly 
binds to the microtubule minus end-directed motor dynein for transport to the nucleus. The 
dynein cofactor dynactin enhances nuclear transport of HAdV and boosts infection. To 
determine if dynactin has a specific role in cytoplasmic trafficking of incoming HAdV on 
microtubules, we used live cell spinning disc confocal microscopy at 25 Hz acquisition 
frequency and automated tracking of single virus particles at 20–50 nm spatial resolution. 
Computational dissection by machine-learning algorithms extracted specific motion 
patterns of viral trajectories. We found that unperturbed cells supported two kinds of 
microtubule-dependent motions, directed motions (DM) and fast drifts (FD). DM had 
speeds of 0.2 to 2 µm/s and run lengths of 0.4 up to 7 µm, while FD were slower and less 
extensive at 0.02 to 0.4 µm/s and 0.05 to 2.5 µm. Dynactin interference by overexpression 
of p50/dynamitin or a coiled-coil domain of p150/Glued reduced the speeds and amounts 
of both center- and periphery-directed DM but not FD, and inhibited infection. These 
results indicate that dynactin enhances adenovirus infection by increasing the speed and 
efficiency of dynein-mediated virus motion to the nucleus, and, surprisingly, also supports 
a hereto unknown motor activity for virus transport to the cell periphery. 
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1. Introduction 
Viruses receive extensive assistance from the host cells for infection. To enter into cells, they utilize 
receptors for attachment and movement on the cell surface [1], or employ signaling machineries and 
endocytic pathways; for reviews, see [2–4]. They escape to the cytosol by membrane fusion in the case 
of enveloped viruses [5], or membrane disruption in the case of nonenveloped viruses [6]. In the 
cytosol, subviral particles consisting of protein-encapsidated genomes are trafficked to sites for 
replication, and this trafficking often involves microtubules [7–9]. Many viruses that replicate in the 
nucleus use the dynein/dynactin motor complex to traffic to the nucleus [10,11]. Cytoplasmic dynein is 
responsible for a broad range of cellular functions, including transport of organelles and regulation of 
mitosis [12–14]. It is a large protein complex composed of different subunits, and moves in the range 
of μm/s towards microtubule minus ends, which are organized in the centrosome near the nucleus of 
nonpolarized or migratory cells [15]. In polarized cells, however, microtubule minus ends are oriented 
away from the nucleus. The usage of multiple motors hence might be particularly advantageous for 
viruses, which utilize the nucleus for genome replication. Such viruses comprise influenza viruses, 
herpes viruses or small DNA-tumor viruses, such as human and animal polyomaviruses, 
papillomaviruses and human adenoviruses (HAdV). 
Currently, there are 56 HAdV types known, which are grouped into seven species A to G [16]. 
HAdV are transmitted by respiratory, fecal-oral or fomital routes, and cause respiratory, ocular,   
genito-urinary and gastrointestinal disease. They are nonenveloped viruses and encapsidate a   
double-stranded DNA genome of about 36  kbp. HAdVs were the first respiratory disease causing 
viruses isolated and characterized [17,18]. Adenoviruses also have a longstanding history and have 
been an amazing discovery tool for molecular cell biology. Key host cell functions that have   
been discovered with HAdV include RNA splicing [19,20], interference with class 1 major 
histocompatibility antigen presentation [21], chaperone-mediated protein folding with the viral hexon 
protein and the 100K folding factor [22], DNA replication [23], and paradigms for DNA-tumor 
viruses, particularly HAdV12 in animals [24,25]. More recently, extensive efforts have been made to 
develop adenoviruses into gene delivery vehicles for therapy of diseased cells, or eradication of tumor 
cells; for a review see [26]. 
The adenovirus particle is composed of 12 viral proteins encoded by distinct open reading frames. 
Most of these proteins build up the capsid, and some are associated with the viral DNA enclosed 
within the capsid. The icosahedral capsid of the species C HAdV2 or its quasi-equivalent HAdV5 has 
a triangulation number T = 25, and is composed of the major protein hexon and a number of cementing 
proteins, which secure the stability of the virion [27–29]. Four viral proteins are known to be located 
on the outside of the virion, hexon, protein IX (pIX), penton base and fiber. Fiber proteins protrude 
from the 12 vertices and attach the virus to the cell adhesion receptor CAR (coxsackievirus adenovirus 
receptor), see [30,31]. Alpha v beta 3/5 integrins facilitate dynamin-dependent endocytosis by binding 
to penton base, which anchors the fibers to the particle [32–34]. Viruses then escape from an early Viruses 2011, 3                  
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endosome to the cytosol by activating the internal protein VI [35,36]. Endosomal escape is coupled to 
a stepwise viral uncoating program during entry. Upon engagement with CAR and integrins, the 
virions shed fibers, and release the internal cementing proteins IIIa, V, VI and VIII [35,37,38]. 
A membrane-free subviral particle is released into the cytoplasm. It consists of hexon, a fraction of 
penton base and pIX, which secures the facets and organizes the group of nine hexons, and the viral 
DNA condensed with pV and pVII, and possibly the hexon-associated pVI. The particle then 
translocates towards the nucleus in a bidirectional transport mode that depends on microtubules and 
dynactin [39–43]. Stochastic in silico simulations matching the microtubule-dependent motions of wild 
type HAdV2 or pIX-deleted HAdV2 suggested that during active translocations, 1–3 motors of either 
nuclear or peripheral polarity were engaged simultaneously with one virus particle, although up to 15 
binding sites per virion were estimated to be available for binding [44]. Biochemical binding studies 
with isolated virions and subviral particles then showed that the dynein subunit IC74 (intermediate 
chain 74  kDa) and LIC1 (light intermediate chain 1) interacted with hexon [45]. Functional 
significance for these interactions was furnished by microinjections of anti-dynein or   
anti-hexon antibodies, which inhibited the translocation of cytosolic particles to the nucleus and 
infection [45,46]. Other viral proteins, such as pVI or protease, have also been proposed to bind dynein 
or have suggested to be involved in virus transport in the cytoplasm, but their role is not firmly 
established [47,48]. After reaching the nuclear envelope, the subviral particle attaches to the nuclear 
pore complex by binding to Nup214/CAN, and releases its DNA into the nucleus [49–51]. 
The mechanisms by which the subviral particles reach the nuclear pore complex are still 
incompletely understood. Here, we aimed to clarify the role for the dynein cofactor dynactin in 
microtubule-dependent transport of particles towards the nucleus. Dynactin was initially found as a 
cytosolic factor that activates dynein and enhances dynein processivity [52,53]. It has been implicated 
in many additional functions, such as cargo binding and loading onto microtubules or coordinating the 
activities of opposing motors; for reviews, see [54–56]. Dynactin comprises a rod like filament mainly 
composed of Arp1 (actin-related protein 1). This filament is tethered to p150/Glued by four 
p50/dynamitin subunits. p150/Glued forms an extended antenna-like structure, which binds to 
microtubules by a CAP-Gly domain, and is thought to contact not only cytoplasmic dynein but also 
one or several kinesins. Overexpression of the dynactin subunit p50/dynamitin or the first α-helical 
coiled-coil domain (CC1) of p150/Glued disrupts the intra- and inter-subunit contacts of dynactin, and 
thereby inhibits a wide variety of microtubule-dependent transport processes of cellular and viral 
cargoes [8,56,57]. Here we specifically show that the overexpression of p50/dynamitin or CC1 of 
p150/Glued blocks the fast bidirectional trajectory segments of HAdV with run lengths in the range of 
0.4–7 µm and thereby inhibits infection. 
2. Results 
2.1. Intact Microtubules are Required for Adenovirus Infection and Support Two Types of Directional 
Movements of Incoming Virus Particles 
We first tested if HAdV5 infection of HeLa cells was microtubule-dependent. Cells were either 
treated or not treated with 40  μM nocodazole to depolymerize microtubules, and inoculated with 
HAdV5 encoding luciferase. Nocodazole depleted the microtubules as indicated by anti-α-tubulin Viruses 2011, 3                  
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staining (Figure 1a). It reduced luciferase expression at different multiplicities of infections (MOI) 
both 5 and 9 h post infection (Figure 1b, c). These data are in agreement with earlier results from 
human bronchial epithelial A549 or African green monkey kidney cells, where microtubules enhanced 
HAdV5 infection without affecting the efficiency of viral escape from endosomes [39,42]. 
Figure 1. Adenovirus infection requires intact microtubules. (a) HeLa cells were kept in 
the presence or absence of nocodazole for 30 min, inoculated with 0.5 μg HAdV2-atto565 
and incubated at 4 °C for 30  min. Temperature was shifted to 37 °C and infection 
proceeded for 90 min, cells were fixed with PHEMO fixative [42], processed for DAPI and 
immunostaining against alpha-tubulin and imaged by wide field fluorescence microscopy. 
Scale bars 20  μm. (b,  c) HeLa cells were continuously treated or left untreated with 
nocodazole in Hoechst containing medium, infected with the indicated physical virus 
particle to cell ratios for 5 h (b) or 9 h (c), lysed and luciferase expression was quantified. 
Before cell lyses and in the last 15  min of infection, cells were imaged with an 
ImageXpress Micro Imaging Station (Molecular Devices) in the Hoechst channel. 
Luciferase expression was normalized to the number of nuclei detected in the 16 sites 
imaged per well. An asterisk indicates samples with luciferase expression below the 
detection limit. The means ± SEM of 4 (b) or 3 (c) independent experiments are shown. 
The two-tailed Student's t test was used to determine p-values. 
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We next analyzed the motion patterns of cytosolic HAdV2 particles. For this, we performed live 
cell, spinning disc confocal microscopy to observe the motions of single virus particles at high   
spatio-temporal resolution (Figure 2a, and Supplemental Movie 1). HAdV2 particles labeled with the 
organic dye Atto565 (HAdV2-atto565) were bound to untreated or nocodazole treated cells in the cold. 
Movies with a length of 80 s (equivalent to 2000 frames at 25 Hz acquisition frequency) were acquired 
between 30 and 90 min post warming at 37 °C. At these time points the majority of virus particles are 
in the cytosol and only 10 to 20% are in endosomes as indicated by transmission electron microscopy 
analyses [58]. Fluorophore-tagged viruses in endosomes at 30 min or later post infection (p.i.) can be 
readily distinguished from cytosolic particles by their heterogeneous intensities due to accumulation of 
multiple particles in individual late endosomes or lysosomes [34,39]. For analyses of individual 
cytosolic particles we used a particle tracker with a precision of approximately 20–50 nm resolution 
[59], and analyzed particle trajectories from the homogenous population using a previously published 
trajectory segmentation algorithm based on specific training data and support vector machines [60]. 
In control cells we found so-called directed motion (DM) segments, which were composed of 
unidirectional steps and had rather high overall speeds of 0.2 to 2 µm/s and long run lengths of 0.4 up 
to 7 µm (Figure 2b, Figure 5c). DM accounted for about 2% of the live time of the particles in the 
cytoplasm (Figure 2c). We also detected unipolar fast drifts (FD), which were slower (0.02 to 
0.4 µm/s) and shorter (0.05–2.5 µm) than DM. Their abundance was similar to the DM. In addition to 
DM and FD, we found slow drifts (SD) [60], which resembled FD in terms of abundance but had 
lower speed (0.002 to 0.015 µm/s). Finally, we observed extensive periods of confinement in areas of 
about 100 nm in diameter (data not shown), and [60]. 
These confinements had no detectable overall movement directionality and accounted for more than 
40% of the live time of the particles in the cytoplasm. All the motion steps that did not fall into any of 
the above described categories were assigned as not classified. They comprised nearly 50% of the 
particles life time, and remain to be mechanistically explored in the future. Importantly, in nocodazole-
treated cells, the abundance of DM and FD were significantly reduced compared to control cells, while 
all other motion patterns were similar or more abundant than in control cells (Figure 2c). 
We next assigned a directionality feature to DM and FD, namely center or periphery direction. 
Motion segments running perpendicular to the axis between the particle and the center of the nucleus 
were termed ‘non-classified’. Nocodazole strongly reduced both the periphery and center-directed DM 
and FD from about 1% to 0.1 to 0.2% in each case, and also significantly depleted the   
non-classified DM and FD (Figure 2d). We conclude that both DM and FD are microtubule-dependent 
motility types of incoming HAdV2 and are directed towards or away from the nucleus (for enlarged 
examples of DM and FD, see Figure 3). 
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Figure 2. Live cell imaging and trajectory segmentations reveal distinct HAdV motion 
patterns. (a) HeLa cells were infected with HAdV2-atto565, and imaged between   
30–90 min p.i. Time stacks were processed with a particle tracker yielding single virus 
trajectories. Trajectories of viruses that are visible for at least 100 frames are show. The 
size and intensity of the signal recorded from the virus particles depends on the imaging 
plane, and the particles brightness. Viruses and corresponding trajectories are numbered 
(1–12). Please note that virus 1 gives rise to trajectories 1–3, for example, since this virus 
is moving in and out of the imaging plane (see also Supplemental Movie 1). Trajectories 
10–12 are from viruses that are not visible in the particular still image, but are visible in 
the supplemental movie. Scale bar 8  μm, cross indicates the center of the nucleus.   
(b) Directed motions (DM, red), fast drifts (FD, pink), confined motions (CM, green) and 
not classified (NC, blue) as identified machine learning and trajectory segmentation. 
Arrow head indicates the start, double arrow heads the end of two trajectories, and 
numbers correspond to particles and trajectories in panel (a). Scale bar 2  μm. (c) The 
number of motion steps of a particular motility type is shown as a fraction of the total 
number of motion steps. The median and the 95% confidence interval obtained by 
bootstrapping are shown; n = number of tracks. (d) The directionality of the motion 
segments from the data set in (c) was classified as described in the Materials and Method 
section with the median and the 95% confidence interval obtained by bootstrapping. 
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Figure 2. Cont.  
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Figure 3. Representative examples for directed motions (DM) and fast drifts (FD). HeLa 
cells infected with HAdV2-atto565 were imaged and a particle tracker was used to obtain 
single virus trajectories. Trajectories were segmented and short stretches of a directed 
motion (DM, red) and a fast drift (FD, magenta) are shown. Scale bar represents 160 nm. 
DM: directed motion
FD: fast drift
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2.2. Dynactin Enhances Infection and Supports Long and Fast Center- and Periphery-Directed 
Adenovirus Motion Runs 
Recent biochemical evidence suggested that dynein is recruited to HAdV5 by direct interaction of 
the intermediate chain 74 and light intermediate chain 1 with the hexon protein of the capsid [45]. 
Based on p50/dynamitin overexpression [61], it was also noticed that dynactin enhanced HAdV2/5 
infection [39,45]. To address the question of how dynactin is involved in HAdV infection, we 
overexpressed two peptides of the dynactin complex, p50/dynamitin tagged to monomeric   
A206K-EGFP (here referred to as mEGFP) and CC1 domain from p150/Glued tagged to mEGFP. 
mEGFP has minimal hydrophobic aggregation and self-association, and hence is well suited for 
mechanistic analyses [62]. Overexpression of p50-mEGFP or mEGFP-CC1 induced scattering of the 
Golgi apparatus 16 h post transfection as judged by indirect immunofluorescence staining of giantin 
(Figure 4a). 
As expected, the overexpression of p50-mEGFP or mEGFP-CC1 did not apparently alter the   
β-tubulin staining in PHEMO-fixed cells, as indicated by indirect immunofluorescence microscopy 
(Figure 4b), in agreement with earlier observations [61]. It did, however, inhibit HAdV5 infection, as 
indicated by luciferase transgene expression at MOI 50 to 5000 physical particles/cell (corresponding 
to 2 to 200 infectious particles/cell) compared to cells expressing mEGFP alone (Figure 5). We 
concluded that dynactin is required for efficient HAdV2/5 infection. Motility analyses showed that the 
expression of p50-mEGFP or mEGFP-CC1 inhibited the DM but not FD or SD, and enhanced the 
confined motions (Figure 6a). Directionality analyses indicated that, surprisingly, both the center- and 
the periphery-directed DM were reduced by the expression of p50-mEGFP or mEGFP-CC1 
(Figure 6b). 
Figure 4. Overexpression of p50-mEGFP or mEGFP-CC1 induces Golgi fragmentation. 
HeLa cells were seeded on glass cover slips and transiently transfected with mEGFP,   
p50-mEGFP, or mEGFP-CC1 for 16 h, fixed with (a) paraformaldehyde or (b) PHEMO fix 
and processed for DAPI and immunostaining against (a) giantin or (b) β-tubulin. Scale 
bars 20 μm. 
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Figure 4. Cont.  
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Figure 5. Dynactin interference inhibits HAdV5 transduction. HeLa cells were transiently 
transfected with mEGFP, p50-mEGFP or mEGFP-CC1 for 16  h, incubated in Hoechst 
containing medium and infected with the indicated virus particle to cell ratios for 9 h. Cells 
were imaged with an ImageXpress Micro Imaging Station (Molecular Devices) in the 
Hoechst and mEGFP channel 30 min before lysis and luciferase expression was detected, 
normalized to the average mEGFP expression and to number of nuclei detected in 16 sites 
imaged per well. The mean values ± SEM of three independent experiments are shown.  
* indicates samples with luciferase expression below the detection limit, ** p < 0.02,   
*** p < 0.005. 
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To further examine the effects of dynactin inhibition on adenovirus motions, we extracted single 
DM run properties, such as run length and speed. The results show that mEGFP-CC1 significantly 
reduced the median speeds of center- and periphery-directed DM runs from 726 to 641 nm/s, and 
709  nm/s to 587  nm/s, respectively, compared to untreated cells (Figure 6c). More specifically, 
mEGFP-CC1 inhibited the center-directed runs faster than 1243  nm/s (p = 0.004), and the   Viruses 2011, 3                  
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periphery-directed runs faster than 1105 nm/s (p = 0.0003). It also reduced the median run length of 
periphery-directed runs from 1013 nm to 826 nm, and specifically the run lengths of center-directed 
runs longer than 3407  nm (p = 0.03). p50-mEGFP expression reduced the median speed of   
periphery-directed runs from 709 nm/s to 638 nm/s, and specifically inhibited periphery-directed runs 
faster than 1541  nm/s (p = 0.02). The distribution of DM run lengths and speeds from mEGFP 
transfected cells were similar to untreated cells also containing high values for run length and speeds 
(data not shown). Taken together, these results support a key role of dynactin in fast and long motions 
of HAdV2/5 either directed to the periphery or the center. The data imply that besides the minus 
end-directed microtubule motor dynein and its cofactor dynactin, a plus end-directed motor could be 
important for the fast movement of adenovirus particles in the cytosol, and could also enhance 
infection, similar to dynein. Furthermore, the number of DM runs per track was reduced from 31% in 
untreated cells to 11% and 19% respectively, in mEGFP-CC1 and p50-mEGFP expressing cells 
(Table 1). 
Figure 6. Dynactin supports long and fast microtubule-dependent motion runs. HeLa cells 
were seeded on glass cover slips and left untransfected or transiently transfected with 
mEGFP, p50-mEGFP or mEGFP-CC1 for 16 h. Cells were infected with HAdV2-atto565 
and viral trajectories acquired 30–90 min p.i. with number of tracks (n). (a) The time that 
the viruses spent in certain motility types is shown as a fraction of total time with the 
median and the 95% confidence interval obtained by bootstrapping. (b) The data shown in 
(a) were grouped according to their directionality with the median and 95% confidence 
interval. (c) Representation of speed and run length histograms for DM runs. The 
frequency was normalized to the number of total DM for each condition. Note that the 
dataset for untreated cells is considerably larger than the datasets for the other conditions, 
and therefore the histogram for untreated cells appears smoother. Vertical red lines and red 
numbers with p-values in parentheses indicate the median for each dataset. Asterisks 
indicate medians that are significantly lower (*) than the median of untreated cells   
(p < 0.05). A threshold zone is indicated by a horizontal black line with the p-value 
representing the probability to draw a random sample (which has the size s as indicated) 
from the untreated dataset, which does not contain any value above the indicated threshold. 
c = number of cells; n = number of tracks; s = number of segments. 
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Figure 6. Cont.  
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Table 1. Dynactin interference reduces the number of directed motions (DM). 
Construct  No. of tracks  No. of DM runs  DM runs per track [%] 
mEGFP 1585  484  31% 
mEGFP-CC1 1333  151  11% 
p50-mEGFP 1829  354  19% 
HeLa cells were transiently transfected with mEGFP, mEGFP-CC1 or p50-mEGFP and infected 
with HAdV2-atto565. Single particle tracking yielded cytoplasmic viral trajectories (Column 2), 
which were segmented into distinct motion patterns, such as directed motions (DM). Dynactin 
interference reduced the total number of DM (Column 3), and also the number of DM per track 
(Column 4). 
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3. Discussion 
The typical motion pattern of cellular and viral cargoes in the cytoplasm resembles stop-and-go 
traffic in forward and backward directions, and rarely looks like smooth gliding to the destination of 
interest. It is thought that bidirectional movements on microtubules help the attached motors to 
navigate cargo through a crowded cytoplasm. Rapid switching between plus and minus end-directed 
movements may occur stochastically, or aspects thereof may be regulated, for example, at the level of 
the cargo, the motor or the microtubule tract [63,64]. 
It is possible, though unlikely, that at any given time point there is only one motor-type bound to 
the cargo, and another motor-type is recruited to switch the transport directionality. Perhaps more 
likely, both types of motors are simultaneously bound to the cargo, but only one type is active during 
directional motion runs, or one type of motor is more abundant on the cargo than the other. Switching 
directionality may occur by yet unknown regulatory mechanisms, or may occur stochastically in an 
unregulated tug-of-war between motors of opposite directionality simultaneously bound to the cargo 
[44,65]. 
For adenovirus, the on and off-rates of motors from microtubules (or cargo) and the motor 
displacement rates have been modeled by stochastic simulation and shown to match the viral 
movements on microtubules in live cells [44]. This suggested that directional movements of 
adenovirus can arise by stochastic binding, unbinding and stepping of motors, and bidirectionality may 
be a consequence of resolving tug-of-war situations.  
Besides stochasticity, there are aspects of motor function in adenovirus infection that may be 
regulated. For example, incoming HAdV2/5 activate a signaling cascade involving protein kinase A 
and p38/MAPK, which favor dynein/dynactin-mediated translocation of subviral particles towards the 
nucleus [41]. Dynactin is an important cofactor for dynein and enhances adenovirus infection [39,43].  
Using wide field fluorescence microscopy at low temporal resolution of 1  Hz and focusing on 
trajectories larger than 100 motion steps, these studies found that the overexpression of p50/dynamitin 
reduced the mean speed of both center- and periphery-directed motion steps and also the number of 
steps directed to the nucleus, and increased the motion-free periods. 
Since p50 can bind proteins other than dynactin, such as MacMARCKS or BICD2 [66,67], we 
extended these studies by expressing the first coiled-coil domain CC1 of the dynactin subunit 
p150/Glued. CC1 expression saturates the dynactin binding site on dynein, and thereby displaces 
dynactin from dynein motor. Virus movement analyses were conducted at high temporal resolution of 
25 Hz, which is a substantial improvement in temporal resolution compared to earlier studies [39]. 
This allowed us to use automated virus tracking with high fidelity.  
Our new results show that interference with mEGFP-CC1 or p50-mEGFP suppressed the fast 
microtubule-dependent speeds of cytosolic HAdV2. Remarkably, mEGFP-CC1 expression 
significantly reduced both center- and periphery-directed motions, while p50-mEGFP significantly 
reduced the periphery-directed speeds and slightly the center-directed speeds. This suggests that 
dynactin directly or indirectly regulates dynein and a plus end-directed motor transporting HAdV2/5. 
This reflects earlier observations in Drosophila neuronal cells, where interference with normal 
dynactin assembly by genetic mutations or RNA interference disrupted both anterograde and 
retrograde transport of organelles, but did not interfere with dynein attachment to cargo [68].  Viruses 2011, 3                  
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Therefore, certain aspects of opposing motor functionality are likely to be coordinated by dynactin. 
Recent evidence from cell cultures supports this notion. It was shown that microtubule-dependent 
transport of peroxisomes in center or periphery direction required two opposite polarity motors, dynein 
and kinesin-1 [69]. These organelles stalled, if either kinesin-1 or dynein was absent. Peroxisome 
movement in both directions could be restored when a different kinesin was ectopically targeted to the 
organelle, suggesting that dynein-mediated runs require a plus end-directed opposing motor. 
Concerning adenovirus transport, we suggest that dynein and an unknown plus end-directed motor 
are coordinated by dynactin to enhance the bidirectional movements of HAdV2/5. By providing a 
mechanical link between motors of opposite polarity, dynactin could activate one of the opposing 
motors, and enhance the probability that one of the motors starts running. Biochemical work in 
melanophores showed that dynactin can bind to dynein or in this case kinesin-2 but not 
simultaneously, suggesting a mechanism by which dynein could regulate direction [70]. Once the 
motor is running, dynactin may balance the opposing motor, and thereby enable the fast DM motions 
of adenovirus.  
Interestingly, a basic sequence motif in p150/Glued is thought to function as a skater and 
progressively glides along microtubules, thereby increasing the processivity of dynein and prolonging 
the interaction time of the motor with microtubules [71,72]. The CAP-Gly domain of p150/Glued on 
the other hand leads to motor stalling but keeps the motor on microtubules [71]. 
Interference with dynactin suppressed the processive DM but not the FD runs of adenovirus. This 
suggests that FD are mediated by dynein and the opposing motor alone without functional dynactin. 
This scenario is similar to a proposed role for dynactin in kinesin-2 and dynein-mediated bidirectional 
movement of melanosomes in Xenopus laevis melanophores, where p150/Glued recruits the cargo 
binding portion of kinesin-2 [70], and enhances the processivity of kinesin-2 in cell-free systems [73]. 
This model is also consistent with the notion that dynein binds directly to the viral hexon [45]. To 
establish the biophysical difference between DM and FD in molecular terms, individual motor 
stepping events need to be resolved by enhanced imaging and further increased spatio-temporal 
resolution of virus trajectories. 
4. Materials and Methods 
4.1. Cells, Viruses and Plasmids 
HeLa cells were kindly provided by U. Kutay (ETH Zurich, Switzerland) and human epithelial KB 
cells were obtained from ATCC (American Type Culture Collection, USA). Cells were subconfluently 
cultured in Dulbecco’s modified Eagle’s medium (D-MEM) supplemented with 2  mM Glutamine 
(Sigma-Aldrich, Buchs, Switzerland), 10% fetal bovine serum, and 1% nonessential amino acids 
(Gibco-BRL, Invitrogen, Basel, Switzerland). HAdV2 was propagated in and isolated from KB cells. 
Viruses were purified and labeled with atto565 (Atto-tec, Siegen, Germany) as previously described 
[37]. The luciferase reporter virus Luc-Ad5 is described in [42] and was kindly provided by S. Hemmi 
(University of Zurich). The EGFP-N1 and EGFP-C1 plasmids were obtained from Clontech (BD 
Biosciences, USA). 
The construct mEGFP-CC1 was cloned by inserting the chicken CC1 domain of p150/Glued [57] 
into the pEGFP-C1 vector (Clontech) employing the restriction sites EcoRI and BamHI. The Viruses 2011, 3                  
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restriction sites were introduced into the CC1 domain using the following primers: CGGAAT-
TCCGAGGAAGAAAATCTGCGTTCC and CGGGATCCCGCTACTGCTGCTGCTTCTCTGC. The 
construct p50-EGFP was kindly provided by R. Vallee (Columbia University, NY, USA). In both  
plasmids mentioned above, the A206K mutation [74] was introduced into EGFP employing the 
following primers: CCTGAGCACCCAGTCCAAGCTGAGCAAAGACCCCA and TGGGGTC-
TTTGCTCAGCTTGGACTGGGTGCTCAGG according to the strategy described in the manual for 
the QuikChange Site-Directed Mutagenesis Kit (Stratagene, Texas, USA). 
4.2. Luciferase Assay 
For dynactin interference experiments, HeLa cells were transfected with the Neon Transfection 
System (Invitrogen, Basel, Switzerland) according to the manufacturer’s protocol. For all other 
experiments cells were left untreated. Subsequently, 25,000 cells were seeded into an imaging 
compatible 96-well imaging plates (Matrix) kept in full D-MEM medium in a humidified incubator for 
16 h at 37 °C and 5% CO2. The next morning, medium was replaced by HEPES buffered RPMI-1640 
medium (Sigma-Aldrich, Buchs, Switzerland) supplemented with 0.2% bovine serum albumin 
(Sigma-Aldrich, Buchs, Switzerland). For all nocodazole conditions the media throughout the 
experiment contained 40 μM nocodazole (Sigma-Aldrich, Buchs, Switzerland). Cells were kept at 4 °C 
for 30 min, and subsequently shifted to 37 °C for 1 h. Medium was replaced by full D-MEM medium 
containing Hoechst 33342 (Sigma-Aldrich, Buchs, Switzerland) and Luc-Ad5. Infection proceeded for 
5  h or 9  h at 37 °C and 5% CO2. During the last 30  min of infection, plates were sealed with 
translucent tape, and cells were imaged in an ImageXpress Micro (Molecular Devices, Ismaning, 
Germany) automated imaging station. The station is equipped with a CERMAX arc Xenon lamp 
(PerkinElmer, Schwerzenbach, Switzerland) for bright illumination, an S Fluor 10x objective, as well 
as BrightLine filter cubes (DAPI-5060B-NTE-ZERO and GFP-3035B-NTE-ZERO, Semrock, 
Rochester, NY). For each well, 16 sites were imaged in the DAPI and GFP channels. The imaging 
chamber was heated to 37 °C during image acquisition. Subsequently, cells were washed with PBS, 
and lysed with reporter lysis buffer (RLB, Promega, Mannheim, Germany) according to the 
manufacturer’s protocol. Luciferase expression was detected with the Luciferase Assay System and a 
GloMax Multi Detection System (Promega, Mannheim, Germany). The number of cells per well was 
determined in DAPI images and the average fluorescent intensity around the nuclear rim was measured 
from GFP images with custom written MATLAB (MathWorks, Natick, MA, USA) scripts. The 
luciferase signal was normalized to the number of nuclei detected on 16 images per well and 
normalized to the mEGFP expression level if applicable. 
4.3. Transfections and Microscopy of Immunostained Cells 
Cells were seeded with 30% confluency on cover glasses (Assistent, Germany) and were 
transfected 6  h later using FuGENE  6 Transfection Reagent (Roche Diagnostics, Mannheim, 
Germany) and serum free D-MEM according to the manufactures protocol. On the next day, cells were 
either fixed with 3% paraformaldehyde (pFA) for 15 min or PHEMO fixative [42] for 10 min, treated 
with 25 mM ammonium chloride in PBS for 10 min and permeabilized with 0.5% Triton X-100 in 
PBS for 5  min. Mouse anti-Giantin antibody (H.P. Hauri, University of Basel, Switzerland) or   Viruses 2011, 3                  
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anti-β-tubulin antibody (N357, Amersham) or anti-α-tubulin antibody (1A2) [75] was diluted in PBS, 
containing 10% goat serum (Gibco-BRL, Invitrogen, Basel, Switzerland) and applied to the samples 
for 1 h at room temperature. Subsequently, samples were washed with PBS and immunostained with 
goat anti-mouse-Texas Red (Jackson Immunoresearch, PA, USA) or Alexa Fluo 488 goat anti-mouse 
(Invitrogen, Basel, Switzerland) diluted in PBS containing 10% goat serum and DAPI (Molecular 
Probes, Leiden, The Netherlands) with the concentration indicated by the manufacturer for 15 min at 
room temperature. Cells were washed with PBS and mounted in 4 µL mounting medium (DAKO, 
Carpinteria, CA, USA) on object slides (Menzel Gläser, Braunschweig, Germany). Images were 
acquired either with an Olympus IX81 inverted epifluorescence microscope equipped with a PlanApo 
60x oil immersion objective controlled by the CellM software (Olympus Optical AG, Switzerland) or 
with an Leica SP5 scanning confocal microscope controlled by Leica LAS AF software (Leica 
Microsystems, Wetzlar, Germany). 
4.4. Live Cell Imaging 
For live cell imaging, cells were seeded at 20% confluency on 18 mm cover slips imaging (Menzel 
Gläser, Braunschweig, Germany) and transfected as described above. On the next day, cells were 
either treated with 20  µM nocodazole (Sigma-Aldrich, Buchs, Switzerland) in D-MEM or left 
untreated for 30 min. Subsequently, they were washed with PBS and 0.8 μg of HAdV2-atto565 were 
applied to the cells. Viruses were allowed to bind to the cell surface at 4 °C in RPMI medium 
(Gibco-BRL) supplemented with 0.2% BSA for 30 min, washed with serum free D-MEM containing 
0.2% BSA and warmed to 37 °C in an incubator containing 5% CO2. 
Time-lapse fluorescence microscopy was performed 30 to 90 min post warming in Hank’s Buffered 
Salt Solution (Gibco-BRL) supplemented with 0.5% BSA and 1  mg/mL ascorbate at pH  7.3 in a 
temperature controlled incubator box at 37 °C (Live Imaging Services, Switzerland). Spinning disc 
confocal microscopy was conducted with a Yokagawa disc system on an Olympus IX81 inverted 
microscope equipped with a Yokogawa scanning head QLC100 (VisiTech International, UK) a triple 
bandpass dichroic mirror (488 nm/565 nm/647 nm, Chroma, USA) and a N.A. 1.35 UPlanApo 100x oil 
immersion objective (Olympus Optical AG, Switzerland). Images were recorded onto   
a 512 × 512 pixel chip (16 × 16 µm per pixel) of a cooled, back-illuminated, 16-bit monochrome CCD 
camera (Cascade 512, Roper Scientific, USA). Fluorophores were excited with an Innova 70C   
mixed-gas laser (Coherent, Germany) with 488 nm and 568 nm, respectively. The microscope and 
camera were controlled with the Metamorph software package (Universal Imaging, USA). 
4.5. Data Analysis 
Time stacks comprising 2000 frames taken at 25 Hz were processed with a single particle tracking 
software [59] to extract 2D trajectories of moving virions. The signal-to-noise ratio was 2.5 allowing 
to determine the virus particle position with an estimated accuracy of 20–50 nm [59]. Along with each 
time stack an image of the cell in the DIC (differential interference) channel was taken. Visual 
inspection of the DIC images allowed the extraction of the center coordinates of the cell nucleus. 
Further post processing procedures were implemented in MATLAB (MathWorks, Natick, MA, USA). 
Trajectories of virions that were visible in less than 100 of the 2000  frames were removed and Viruses 2011, 3                  
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remaining trajectories were processed with a supervised trajectory segmentation algorithm based on 
Support Vector Machines as classifiers [60]. This procedure aimed at the detection of distinct,   
non-random, motion patterns in HAdV2 trajectories. Trajectory segments were classified as confined 
motions (CM), slow drifts (SD), fast drifts (FD), directed motions (DM) and not classified. 
For each segment the distance from the segment start point coordinates to the cell center (d S-C) 
was compared with the distance of the cell center to the segment endpoint coordinates (d C-E). If d  
S-C > d C-E, the corresponding segment was classified as center-directed. If d S-C < d C-E, the 
segment was classified as periphery-directed. Segments with a distance difference of d S-C and d C-E 
less than one image pixel (160  nm) were directionally not classified. These motion segments 
corresponded to tangential virus movement with respect to the nucleus. The run length of a segment 
was defined as the net distance from the start point of the segment to its endpoint. Taking the imaging 
frequency into consideration, the duration of a segment was calculated from the number of frames of 
the track. Dividing the segment run length by its duration yielded the segment speed. A   
particle-frame was defined as one particle that is visible during one frame. The abundance of one 
motility type is calculated as the number of particle-frames that virions spent in a certain motility type 
divided by the number of particle-frames of all virions. 
Populations of DM speeds and run length were characterized by calculating median speeds (nm/s) 
and run lengths (nm) with the according probabilities that they are different from the dataset of 
untreated cells. A Kolmogorov-Smirnov test was used to test if the measurements were normally 
distributed or not. With very high confidence none of the speed and run length distributions was 
normal. The Wilcoxon rank sum test for equal medians of two continuous distributions was used to 
compare the median values of mEGFP-CC1 and p50-mEGFP distributions with the untreated cells. 
The null hypothesis was that the two independent samples had equal medians. The alternative 
hypothesis was that the samples did not have equal medians. Probability calculations of drawing a 
random sample of size s from the control condition without sampling values above the thresholds were 
performed (Figure 6c). The control dataset was significantly larger than the datasets of CC1-EGFP and 
p50-EGFP. We were concerned about the possibility that absence of segments with high speeds could 
be due to small datasets. Therefore, we estimated the likelihood of drawing a random sample of size s 
from the control dataset that had no values above a certain threshold T. In a first step the probability of 
experimental values below the threshold was calculated for the control dataset   
(Plow = events below threshold T/all events). The probability of drawing a random sample of size s 
with all values below Plow is: 
Prandom = Plow
s
 
The number of segments in the dataset of CC1-EGFP and p50-EGFP was used as s. The values for 
Prandom were calculated. Values of Prandom < 0.05 indicated a low probability of observing a distribution 
without values above the threshold T by chance. 
5. Conclusions 
The data presented here and earlier results show that dynactin supports microtubule-dependent 
directional motions of HAdV2/5 particles both towards and away from the nucleus, and thereby Viruses 2011, 3                  
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enhances the nuclear localization of HAdV2/5 and infection. How the viruses detach from 
microtubules near the nucleus, and attach the nuclear pore complexes for uncoating of their DNA is 
subject to future studies. 
Supplementary Materials 
Supplemental Movie 1. Intracellular trajectories of HAdV2-atto565. HAdV2-atto565 was bound to 
HeLa cells at 4 °C for 30 min, unbound virus washed off, and cells were shifted to 37 °C for 47 min, 
followed by imaging of 2000 frames at an acquisition frequency of 25 Hz. Scale bar corresponds to 
8 μm. 
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